Physician profile
Katherine Makayed
NPI 1245741537
$1,918.74
in general payments reported to CMS, 2019-2025
10 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2021: $515 · 2022: $211 · 2023: $251 · 2024: $404 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $614.71 | 2019-2025 | Acuvue |
| Coopervision INC. | $386.81 | 2019-2024 | Misight Contact Lens |
| Visioneering Technologies, INC. | $288.24 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $274.37 | 2019-2021 | |
| Sight Sciences, INC. | $148.99 | 2024 | Omni Surgical System |
| Alcon Vision LLC | $71.28 | 2023-2025 | Dailies Total1, Precision7 |
| Abbvie INC. | $52.29 | 2023-2024 | |
| Biotissue Holdings INC. | $46.28 | 2023 | |
| Sun Pharmaceutical Industries INC. | $18.42 | 2021 | |
| Optos, INC. | $17.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Makayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.